|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Anemia | |||||
| 2 | More general conditions related to this trial | ||||
| Hematologic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| epoetin alfa or beta | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Epoetin Alfa | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hematinics | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Hoffmann-La Roche | |||||